Charu Aggarwal

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Charu Aggarwal sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials none currently recruiting upper half by trial count

Charu Aggarwal: 1 sponsored US clinical trial, none currently recruiting.

Charu Aggarwal sponsors 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most-studied condition in this pipeline is Non-Squamous Non-Small Cell Neoplasm of Lung, with 1 trials.

Mid-pack sponsor footprint

Charu Aggarwal is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

How the Charu Aggarwal archive is shaped

1 indexed studies, none listed as recruiting (0% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Non-Squamous Non-Small Cell Neoplasm of Lung (1 trial), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Charu Aggarwal: archived-pipeline peers nationwide

Peers matched on 1 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Charu Aggarwal sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%20%40%60% Total trials Recruiting share Charu Aggarwal1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO Health10xBio22nd Century Group23andMe3-C Institute for Social Development
Charu Aggarwal sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Charu Aggarwal sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Charu Aggarwal page

1 registered trials is a research-attention snapshot, not an endorsement of Charu Aggarwal or any single study.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Charu Aggarwal pipeline card: 1 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.